RMD · NYSE
ResMed Inc.
$252.86 -0.32 (-0.12%)
Company overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments: Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies for medical and consumer products, ventilation devices, diagnostic products, mask systems for use in hospitals and homes, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as customer and business process services.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $35.6B
- Employees
- 9,980
- Headquarters
- San Diego, CA
- Website
- resmed.com
- CEO
- Michael J. Farrell
- Listed
- June 2, 1995
- P/E
- 24.36
- Dividend yield
- 1.08%
Company financials
- Revenue
- $5.5B
- Gross profit
- $3.4B
- Operating income
- $1.9B
- EBITDA
- $2.1B
- Net income
- $1.5B
- EPS
- $10.38
- Total assets
- $8.8B
- Total debt
- $843M
- Gross margin
- 61.69%
- Net margin
- 27.44%
- Earnings yield
- 4.11%
Showing FY 2024
RMD
1D
NYSE
O245.41H253.62L244.18C253.06+6.86 (+2.79%)Vol1.73M